These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 25776891)

  • 1. Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study.
    Mellinger JL; Pencina KM; Massaro JM; Hoffmann U; Seshadri S; Fox CS; O'Donnell CJ; Speliotes EK
    J Hepatol; 2015 Aug; 63(2):470-6. PubMed ID: 25776891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study.
    VanWagner LB; Ning H; Lewis CE; Shay CM; Wilkins J; Carr JJ; Terry JG; Lloyd-Jones DM; Jacobs DR; Carnethon MR
    Atherosclerosis; 2014 Aug; 235(2):599-605. PubMed ID: 24956534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study.
    Khawaja T; Linge J; Leinhard OD; Al-Kindi SG; Rajagopalan S; Khera A; de Lemos JA; Joshi P; Neeland IJ
    Prog Cardiovasc Dis; 2023; 78():67-73. PubMed ID: 36931545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greater Volume but not Higher Density of Abdominal Aortic Calcium Is Associated With Increased Cardiovascular Disease Risk: MESA (Multi-Ethnic Study of Atherosclerosis).
    Forbang NI; Michos ED; McClelland RL; Remigio-Baker RA; Allison MA; Sandfort V; Ix JH; Thomas I; Rifkin DE; Criqui MH
    Circ Cardiovasc Imaging; 2016 Nov; 9(11):. PubMed ID: 27903540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver Fat Is Associated With Markers of Inflammation and Oxidative Stress in Analysis of Data From the Framingham Heart Study.
    Fricker ZP; Pedley A; Massaro JM; Vasan RS; Hoffmann U; Benjamin EJ; Long MT
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1157-1164.e4. PubMed ID: 30476583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between hepatic steatosis and incident cardiovascular disease, cancer, and all-cause mortality in a US multicohort study.
    Ahmed HS; Wang N; Carr JJ; Ding J; Terry JG; VanWagner LB; Hou L; Huo Y; Palmisano J; Zheng Y; Benjamin EJ; Long MT
    Hepatology; 2023 Jun; 77(6):2063-2072. PubMed ID: 36651168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Density and morphology of coronary artery calcium for the prediction of cardiovascular events: insights from the Framingham Heart Study.
    Foldyna B; Eslami P; Scholtz JE; Baltrusaitis K; Lu MT; Massaro JM; D'Agostino RB; Ferencik M; Aerts HJWL; O'Donnell CJ; Hoffmann U
    Eur Radiol; 2019 Nov; 29(11):6140-6148. PubMed ID: 31049733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium intake is inversely associated with coronary artery calcification: the Framingham Heart Study.
    Hruby A; O'Donnell CJ; Jacques PF; Meigs JB; Hoffmann U; McKeown NM
    JACC Cardiovasc Imaging; 2014 Jan; 7(1):59-69. PubMed ID: 24290571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study.
    Sinn DH; Kang D; Chang Y; Ryu S; Gu S; Kim H; Seong D; Cho SJ; Yi BK; Park HD; Paik SW; Song YB; Lazo M; Lima JA; Guallar E; Cho J; Gwak GY
    Gut; 2017 Feb; 66(2):323-329. PubMed ID: 27599521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parental occurrence of premature cardiovascular disease predicts increased coronary artery and abdominal aortic calcification in the Framingham Offspring and Third Generation cohorts.
    Parikh NI; Hwang SJ; Larson MG; Cupples LA; Fox CS; Manders ES; Murabito JM; Massaro JM; Hoffmann U; O'Donnell CJ
    Circulation; 2007 Sep; 116(13):1473-81. PubMed ID: 17785619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study.
    Long MT; Zhang X; Xu H; Liu CT; Corey KE; Chung RT; Loomba R; Benjamin EJ
    Hepatology; 2021 Feb; 73(2):548-559. PubMed ID: 33125745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.
    Kouvari M; Polyzos SA; Chrysohoou C; Skoumas J; Pitsavos CS; Panagiotakos DB; Mantzoros CS
    Clin Nutr; 2022 Jun; 41(6):1281-1289. PubMed ID: 35504171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population.
    Ciardullo S; Cannistraci R; Mazzetti S; Mortara A; Perseghin G
    Front Endocrinol (Lausanne); 2021; 12():711484. PubMed ID: 34381424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Dysfunction-Associated Fatty Liver Disease Better Predicts Incident Cardiovascular Disease.
    Jeong S; Oh YH; Choi S; Chang J; Kim SM; Son JS; Lee G; Kim W; Park SM
    Gut Liver; 2022 Jul; 16(4):589-598. PubMed ID: 34730107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease.
    Marti-Aguado D; Ten-Esteve A; Baracaldo-Silva CM; Crespo A; Coello E; Merino-Murgui V; Fernandez-Paton M; Alfaro-Cervello C; Sánchez-Martín A; Bauza M; Jimenez-Pastor A; Perez-Girbes A; Benlloch S; Pérez-Rojas J; Puglia V; Ferrández A; Aguilera V; Latorre M; Monton C; Escudero-García D; Bosch-Roig I; Alberich-Bayarri Á; Marti-Bonmati L
    Front Endocrinol (Lausanne); 2023; 14():1213441. PubMed ID: 37600695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Nonalcoholic Fatty Liver Disease With Visceral Adiposity but Not Coronary Artery Calcification in the Elderly.
    Jacobs K; Brouha S; Bettencourt R; Barrett-Connor E; Sirlin C; Loomba R
    Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1337-1344.e3. PubMed ID: 26820400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.
    Weinstein G; Zelber-Sagi S; Preis SR; Beiser AS; DeCarli C; Speliotes EK; Satizabal CL; Vasan RS; Seshadri S
    JAMA Neurol; 2018 Jan; 75(1):97-104. PubMed ID: 29159396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease.
    VanWagner LB; Ning H; Allen NB; Ajmera V; Lewis CE; Carr JJ; Lloyd-Jones DM; Terrault NA; Siddique J
    Gastroenterology; 2017 Nov; 153(5):1260-1272.e3. PubMed ID: 28802566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease.
    Semmler G; Balcar L; Wernly S; Völkerer A; Semmler L; Hauptmann L; Wernly B; Aigner E; Niederseer D; Datz C
    Front Endocrinol (Lausanne); 2023; 14():1244405. PubMed ID: 37842290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.
    Motamed N; Rabiee B; Poustchi H; Dehestani B; Hemasi GR; Khonsari MR; Maadi M; Saeedian FS; Zamani F
    Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):31-38. PubMed ID: 27597641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.